Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbidities

Christopher J. Pizzola; Joseph Cioccio; Kevin L. Rakszawski; Myles Nickolich; W. Christopher Ehmann; Witold B. Rybka; Baldeep Wirk; Seema Naik; Hong Zheng; Brooke Silar; Hiroko Shike; Shouhao Zhou; Shin Mineishi; Kentaro Minagawa; David F. Claxton

doi:10.1038/s41409-022-01821-4

Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbidities

Christopher J. Pizzola, Joseph Cioccio, Kevin L. Rakszawski, Myles Nickolich, W. Christopher Ehmann, Witold B. Rybka, Baldeep Wirk, Seema Naik, Hong Zheng, Brooke Silar, Hiroko Shike, Shouhao Zhou, Shin Mineishi, Kentaro Minagawa, David F. Claxton

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1743-1745
Number of pages	3
Journal	Bone Marrow Transplantation
Volume	57
Issue number	11
DOIs	https://doi.org/10.1038/s41409-022-01821-4
State	Published - Nov 2022

All Science Journal Classification (ASJC) codes

Hematology
Transplantation

Access to Document

10.1038/s41409-022-01821-4

Cite this

Pizzola, C. J., Cioccio, J., Rakszawski, K. L., Nickolich, M., Ehmann, W. C., Rybka, W. B., Wirk, B., Naik, S., Zheng, H., Silar, B., Shike, H., Zhou, S., Mineishi, S., Minagawa, K., & Claxton, D. F. (2022). Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbidities. Bone Marrow Transplantation, 57(11), 1743-1745. https://doi.org/10.1038/s41409-022-01821-4

@article{dd44819f887642ee873aa093ce6d78f2,

title = "Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbidities",

author = "Pizzola, {Christopher J.} and Joseph Cioccio and Rakszawski, {Kevin L.} and Myles Nickolich and Ehmann, {W. Christopher} and Rybka, {Witold B.} and Baldeep Wirk and Seema Naik and Hong Zheng and Brooke Silar and Hiroko Shike and Shouhao Zhou and Shin Mineishi and Kentaro Minagawa and Claxton, {David F.}",

note = "Funding Information: This work was supported by the Arlene Witmer Memorial Fund for Bone Marrow Cancer Research, the John and Denise Gilliland Fund for the Cancer Genetics Program, G. R. Sponaugle Employee Cancer Research Fund, Earl “Bumps” Clouser Memorial Lymphoma Research Endowment, and Richard E. and Stephanie A. Ziegler Charitable Foundation Endowment in Hematology. The authors would like to thank the patients who participated in this study and the technicians who participated in the experimental procedures. ",

year = "2022",

month = nov,

doi = "10.1038/s41409-022-01821-4",

language = "English (US)",

volume = "57",

pages = "1743--1745",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Springer Nature",

number = "11",

}

Pizzola, CJ, Cioccio, J, Rakszawski, KL , Nickolich, M , Ehmann, WC , Rybka, WB, Wirk, B, Naik, S , Zheng, H, Silar, B, Shike, H , Zhou, S , Mineishi, S , Minagawa, K & Claxton, DF 2022, 'Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbidities', Bone Marrow Transplantation, vol. 57, no. 11, pp. 1743-1745. https://doi.org/10.1038/s41409-022-01821-4

Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbidities. / Pizzola, Christopher J.; Cioccio, Joseph; Rakszawski, Kevin L. et al.
In: Bone Marrow Transplantation, Vol. 57, No. 11, 11.2022, p. 1743-1745.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbidities

AU - Pizzola, Christopher J.

AU - Cioccio, Joseph

AU - Rakszawski, Kevin L.

AU - Nickolich, Myles

AU - Ehmann, W. Christopher

AU - Rybka, Witold B.

AU - Wirk, Baldeep

AU - Naik, Seema

AU - Zheng, Hong

AU - Silar, Brooke

AU - Shike, Hiroko

AU - Zhou, Shouhao

AU - Mineishi, Shin

AU - Minagawa, Kentaro

AU - Claxton, David F.

N1 - Funding Information: This work was supported by the Arlene Witmer Memorial Fund for Bone Marrow Cancer Research, the John and Denise Gilliland Fund for the Cancer Genetics Program, G. R. Sponaugle Employee Cancer Research Fund, Earl “Bumps” Clouser Memorial Lymphoma Research Endowment, and Richard E. and Stephanie A. Ziegler Charitable Foundation Endowment in Hematology. The authors would like to thank the patients who participated in this study and the technicians who participated in the experimental procedures.

PY - 2022/11

Y1 - 2022/11

UR - http://www.scopus.com/inward/record.url?scp=85137850311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85137850311&partnerID=8YFLogxK

U2 - 10.1038/s41409-022-01821-4

DO - 10.1038/s41409-022-01821-4

M3 - Letter

C2 - 36097041

AN - SCOPUS:85137850311

SN - 0268-3369

VL - 57

SP - 1743

EP - 1745

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 11

ER -

Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbidities

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this